000 01112 a2200313 4500
005 20250512204205.0
264 0 _c19810810
008 198108s 0 0 eng d
022 _a0071-9676
024 7 _a10.1159/000394383
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDavignon, J P
245 0 0 _aDelta-9-tetrahydrocannabinol: comments on antiemetic trials.
_h[electronic resource]
260 _bFrontiers of radiation therapy and oncology
_c1980
300 _a148-56 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBiological Availability
650 0 4 _aClinical Trials as Topic
650 0 4 _aDouble-Blind Method
650 0 4 _aDronabinol
_xmetabolism
650 0 4 _aEuphoria
650 0 4 _aHumans
650 0 4 _aIntestinal Absorption
650 0 4 _aNausea
_xchemically induced
650 0 4 _aNeoplasms
_xdrug therapy
773 0 _tFrontiers of radiation therapy and oncology
_gvol. 15
_gp. 148-56
856 4 0 _uhttps://doi.org/10.1159/000394383
_zAvailable from publisher's website
999 _c6263695
_d6263695